Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma?
Biogen Idec receives notification of PDUFA date extension
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.
The endocannabinoid system and multiple sclerosis.
You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Mutation Analysis of Gap Junction Protein Beta 1 and Genotype-Phenotype Correlation in X-linked Charcot-Marie-Tooth Disease in Chinese Patients.
Defining the Role of Physiotherapy in Palliative Care in Multiple Sclerosis.
Techniques and technologies for the bioanalysis of Sativex(®), metabolites and related compounds.
Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients.
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
Associations Between Fatigue and Disability, Functional Mobility, Depression, and Quality of Life in People with Multiple Sclerosis.
In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade.
Tumefactive multiple sclerosis presenting with tonic-clonic seizure.
Neuroimmunomodulation by allogeneic seminal vesicle fluid in CNS is sex-independent.
Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).
Multiple sclerosis and risk of attempted and completed suicide - a cohort study.
Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.
Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging.
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease.
Reassessing the risk of natalizumab-associated PML.
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.

Pages